Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status.
Myelodysplastic syndromes (MDS) are stem cell disorders of clonal origin in which infections and leukemic transformation are quite frequent. Neutrophils from 28 patients with MDS were analysed by flow cytometry for the expression of the two complement receptors CR1 and CR3, the antigenic reactivity of some granule constituents--myeloperoxidase, lysozyme, elastase, lactoferrin--and functional activities, such as locomotion, respiratory burst and cytotoxicity. The results were correlated with the FAB disease subtypes, grouped as low risk (RA) and high risk patients (RAEB, RAEB-t, CMML) and with 30 healthy subjects. A significant reduction in the percentage of neutrophil CR1, CR3 positivity and chemotaxis induced by endotoxin-activated serum was detected in the high risk group when compared with the low risk group and healthy controls. Furthermore, the high risk group also showed a low amount of myeloperoxidase, elastase, lysozyme and superoxide anion, but both low and high risk groups displayed reduced cellular cytotoxicity in comparison with the control. This work indicates that MDS patients belonging to the more advanced FAB categories frequently show multiple abnormalities in the expression of neutrophil complement receptors, and granular components (> 3), as well as in cell functions, suggesting the possibility of using these phenotypic abnormalities in the monitoring of disease progression.
Moretti
S
S
Hematology Institute, University of Ferrara, Italy.
Lanza
F
F
Spisani
S
S
Latorraca
A
A
Rigolin
G M
GM
Giuliani
A L
AL
Castoldi
G L
GL
Traniello
S
S
D002634:Chemotaxis, Leukocyte; D003594:Cytoplasmic Granules / Q000201:enzymology; D005434:Flow Cytometry; D006801:Humans; D007781:Lactoferrin / Q000032:analysis; D009113:Muramidase / Q000032:analysis; D009190:Myelodysplastic Syndromes / Q000097:blood* / Q000201:enzymology / Q000503:physiopathology; D009504:Neutrophils / Q000201:enzymology / Q000502:physiology* / Q000648:ultrastructure; D010196:Pancreatic Elastase / Q000032:analysis; D009195:Peroxidase / Q000032:analysis; D010587:Phagocytosis; D011951:Receptors, Complement / Q000502:physiology*; D017463:Receptors, Complement 3b / Q000502:physiology*; D013481:Superoxides / Q000097:blood
D011951:Receptors, Complement; D017463:Receptors, Complement 3b; D013481:Superoxides; D009195:Peroxidase; D009113:Muramidase; D007781:Lactoferrin; D010196:Pancreatic Elastase